The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery

Heart

Volumn 96, Issue 19, 2010, Pages 1569-1573

  Plymen, Carla M ^a   Hughes, Marina L ^b   Picaut, Nathalie ^a   Panoulas, Vasileios F ^c   MacDonald, Simon T ^a   Cullen, Seamus ^a   Deanfield, John E ^a   Walker, Fiona ^a   Taylor, Andrew M ^b,d   Lambiase, Pier D ^a   Bolger, Aidan P ^e  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GOLD STANDARD; GREAT VESSELS TRANSPOSITION; HEART FAILURE; HEART RIGHT VENTRICLE; HUMAN; INTERMETHOD COMPARISON; MALE; MUSTARD SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SENNING SURGERY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTOLE; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NATRIURETIC PEPTIDE, BRAIN; PALLIATIVE CARE; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; STROKE VOLUME; TRANSPOSITION OF GREAT VESSELS; VENTRICULAR DYSFUNCTION, RIGHT; YOUNG ADULT;

EID: 77957292384     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.198648     Document Type: Article

References (26)

1. Nieminen H, Jokinen E, Sairanen H. Causes of late deaths after pediatric cardiac surgery. J Am Coll Cardiol 2007;50:1263-71.
2. Gelatt M, Hamilton R, McGrindle B, et al. Arrhythmia and mortality after the Mustard procedure: a 30-year single center experience. J Am Coll Cardiol 1997;29:194-201.
3. Oechslin E, Harrison D, Connelly M, et al. Mode of death in adults with congenital heart disease. Am J Cardiol 2000;86:1111-16.
4. Roos-Hesselink JW, Meijboom F, Spitaels S, et al. Decline in ventricular function after Mustard repair for transposition of the great arteries. Eur Heart J 2004;25:1264-70.
5. Mooji CF, de Wit CJ, Graham DA, et al. Reproducibility of MRI measurements of right ventricular size and function in patients with normal and dilated ventricles. J Magn Reson Imaging 2008;28:67-73.
6. Lorenz CH, Walker ES, Graham TP Jr, et al. Right ventricular performance and mass by use of cine MRI late after atrial repair of transposition of the great arteries. Circulation 1995;92(9 Suppl):II233-9.
7. Diller GP, Dimopoulos K, Okonko D, et al. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates and prognostic implication. Circulation 2005;112:828-35.
8. Dickstein K, Cohen-Solal A, Filippatos G, et al. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
9. Godkar D, Bachu K, Dave B, et al. B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders. Am J Ther 2008;15:150-6. (Pubitemid 351450779)
10. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-9.
11. Tulevski I, Groenink M, van der Wall E, et al. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart 2001;86:27-30.
12. Neffke J, Tulevski I, van der Wall E, et al. ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease; relation with plasma neurohormones and MRI parameters. Heart 2002;88:266-70.
13. Coats L, Tsang V, Khambadkone S, et al. The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention. Eur J Cardiothorac Surg 2005;27:536-43.
14. Coats L, Khambadkone S, Derrick G, et al. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation 2006;113:2037-44. (Pubitemid 43755153)
15. Devos D, Kilner P. Calculations of cardiovascular shunts and regurgitation using magnetic resonance ventricular volume and aortic and pulmonary flow measurements. Eur Radiol 2010;20:410-21.
16. Bolger AP, Coats AJ, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J 2003;24:970-6.
17. Eichhorn EJ. Prognosis determination in heart failure. Am J Med 2001;110(Suppl 7A):14-36S.
18. Koch A, Zink S, Singer H. B-Type natriuretic peptide in patients with systemic right ventricle. Cardiology 2008;110:1-7.
19. Chow P, Cheung E, Chong C, et al. Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation. Int J Cardiol 2008;127:192-7.
20. Garg R, Raman S, Hoffman T, et al. Serum markers of systemic right ventricular function and exercise performance. Pediatr Cardiol 2008;29:641-8.
21. Oosterhof T, Tulevski I, Vliegen H, et al. Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of Fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels. Am J Cardiol 2006;97:1051-5.
22. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
23. Gatzoulis MA, Walters J, McLaughlin PR, et al. Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction? Heart 2000;84:409-15.
24. Sun Z, Happonen J, Bennhagen R, et al. Increased QT dispersion and loss of sinus rhythm as risk factors for late sudden death after Mustard or Senning procedures for transposition of the great arteries. Am J Cardiol 2004;94:138-41. (Pubitemid 38813473)
25. Schwerzmann M, Salehian O, Harris L, et al. Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. Eur Heart J 2009;30:1873-9.
26. Kammeraad J, van Deurzen C, Sreeram N, et al. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004;44:1095-102.